.Attributes Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for introduction of people along with MASLD and measurement of liver end results in cardio-- kidney-- metabolic trials, when records recommend mechanistically plausible perks as well as clinical safety-- and also describes factors for test layout as well as governing commendation.